Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edward Thomas Ryan, D.T.M.&H., M.D.

Co-Author

This page shows the publications co-authored by Edward Ryan and Regina Larocque.
Connection Strength

10.938
  1. Medical Considerations before International Travel. N Engl J Med. 2016 10 13; 375(15):e32.
    View in: PubMed
    Score: 0.682
  2. Pre-travel health advice-seeking behavior among US international travelers departing from Boston Logan International Airport. J Travel Med. 2010 Nov-Dec; 17(6):387-91.
    View in: PubMed
    Score: 0.451
  3. Evaluation of Candida auris acquisition in US international travellers using a culture-based screening protocol1. J Travel Med. 2022 Jan 17; 29(1).
    View in: PubMed
    Score: 0.245
  4. Systemic, Mucosal, and Memory Immune Responses following Cholera. Trop Med Infect Dis. 2021 Oct 27; 6(4).
    View in: PubMed
    Score: 0.242
  5. Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. PLoS Negl Trop Dis. 2021 Jul; 15(7):e0009616.
    View in: PubMed
    Score: 0.237
  6. Acquisition and Long-term Carriage of Multidrug-Resistant Organisms in US International Travelers. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa543.
    View in: PubMed
    Score: 0.228
  7. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility. mBio. 2020 11 17; 11(6).
    View in: PubMed
    Score: 0.226
  8. The effect of transport temperature and time on the recovery of antimicrobial-resistant Enterobacterales in stool. Diagn Microbiol Infect Dis. 2021 Feb; 99(2):115210.
    View in: PubMed
    Score: 0.224
  9. Acquisition of Antibiotic-Resistant Bacteria by U.S. International Travelers. N Engl J Med. 2020 04 02; 382(14):1372-1374.
    View in: PubMed
    Score: 0.217
  10. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers. JAMA Pediatr. 2020 02 01; 174(2):e194515.
    View in: PubMed
    Score: 0.214
  11. Evaluation of a Screening Method for the Detection of Colistin-Resistant Enterobacteriaceae in Stool. Open Forum Infect Dis. 2019 Jun; 6(6):ofz211.
    View in: PubMed
    Score: 0.203
  12. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. J Infect Dis. 2018 07 13; 218(4):645-653.
    View in: PubMed
    Score: 0.192
  13. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. PLoS Negl Trop Dis. 2018 04; 12(4):e0006399.
    View in: PubMed
    Score: 0.189
  14. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. PLoS Negl Trop Dis. 2018 04; 12(4):e0006376.
    View in: PubMed
    Score: 0.189
  15. Travel Medicine. Ann Intern Med. 2018 Jan 02; 168(1):ITC1-ITC16.
    View in: PubMed
    Score: 0.185
  16. Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations. Ann Intern Med. 2017 07 18; 167(2):77-84.
    View in: PubMed
    Score: 0.177
  17. Characteristics of US Travelers to Zika Virus-Affected Countries in the Americas, March 2015-October 2016. Emerg Infect Dis. 2017 02; 23(2):324-327.
    View in: PubMed
    Score: 0.174
  18. Preparing Pediatric International Travelers for Travelers' Diarrhea: Insights From the Global TravEpiNet. Pediatr Infect Dis J. 2017 02; 36(2):242-243.
    View in: PubMed
    Score: 0.174
  19. Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet. J Travel Med. 2016 Jul; 24(1).
    View in: PubMed
    Score: 0.171
  20. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh. Clin Vaccine Immunol. 2016 05; 23(5):427-435.
    View in: PubMed
    Score: 0.165
  21. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice. PLoS Negl Trop Dis. 2015; 9(7):e0003881.
    View in: PubMed
    Score: 0.156
  22. Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh. Am J Trop Med Hyg. 2015 Aug; 93(2):244-249.
    View in: PubMed
    Score: 0.155
  23. Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide. PLoS Negl Trop Dis. 2014 Feb; 8(2):e2683.
    View in: PubMed
    Score: 0.141
  24. Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clin Vaccine Immunol. 2014 Mar; 21(3):280-5.
    View in: PubMed
    Score: 0.140
  25. Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal. PLoS Negl Trop Dis. 2013; 7(8):e2335.
    View in: PubMed
    Score: 0.136
  26. Natural selection in a bangladeshi population from the cholera-endemic ganges river delta. Sci Transl Med. 2013 Jul 03; 5(192):192ra86.
    View in: PubMed
    Score: 0.136
  27. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol. 2013 Jun; 20(6):780-8.
    View in: PubMed
    Score: 0.133
  28. Identification of in vivo-induced bacterial proteins during human infection with Salmonella enterica serotype Paratyphi A. Clin Vaccine Immunol. 2013 May; 20(5):712-9.
    View in: PubMed
    Score: 0.133
  29. Pre-travel health care of immigrants returning home to visit friends and relatives. Am J Trop Med Hyg. 2013 Feb; 88(2):376-380.
    View in: PubMed
    Score: 0.130
  30. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin Vaccine Immunol. 2012 Nov; 19(11):1712-21.
    View in: PubMed
    Score: 0.129
  31. In the clinic. Travel medicine. Ann Intern Med. 2012 Jun 05; 156(11):ITC6-1, ITC6-2, ITC6-3, ITC6-4, ITC6-5, ITC6-6, ITC6-7, ITC6-8, ITC6-9, ITC6-10, ITC6-11, ITC6-12, ITC6-13, ITC6-14, ITC6-15; quiz ITC6-16.
    View in: PubMed
    Score: 0.126
  32. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol. 2012 May; 19(5):690-8.
    View in: PubMed
    Score: 0.124
  33. In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in Bangladesh. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1419.
    View in: PubMed
    Score: 0.122
  34. Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis. 2012 Feb 15; 54(4):455-62.
    View in: PubMed
    Score: 0.122
  35. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clin Vaccine Immunol. 2011 Aug; 18(8):1317-25.
    View in: PubMed
    Score: 0.118
  36. Interferon-? and proliferation responses to Salmonella enterica Serotype Typhi proteins in patients with S. Typhi Bacteremia in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2011 Jun; 5(6):e1193.
    View in: PubMed
    Score: 0.118
  37. Analysis of Salmonella enterica serotype paratyphi A gene expression in the blood of bacteremic patients in Bangladesh. PLoS Negl Trop Dis. 2010 Dec 07; 4(12):e908.
    View in: PubMed
    Score: 0.114
  38. Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology. Clin Vaccine Immunol. 2010 Aug; 17(8):1188-95.
    View in: PubMed
    Score: 0.110
  39. Familial aggregation of Vibrio cholerae-associated infection in Matlab, Bangladesh. J Health Popul Nutr. 2009 Dec; 27(6):733-8.
    View in: PubMed
    Score: 0.106
  40. Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium. PLoS One. 2009 Sep 10; 4(9):e6994.
    View in: PubMed
    Score: 0.104
  41. A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. Genes Immun. 2009 Apr; 10(3):267-72.
    View in: PubMed
    Score: 0.100
  42. Proteomic analysis of Vibrio cholerae in human stool. Infect Immun. 2008 Sep; 76(9):4145-51.
    View in: PubMed
    Score: 0.096
  43. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice. Infect Immun. 2006 Oct; 74(10):5834-9.
    View in: PubMed
    Score: 0.085
  44. Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun. 2006 Sep; 74(9):5161-8.
    View in: PubMed
    Score: 0.085
  45. Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. Am J Trop Med Hyg. 2006 Jun; 74(6):1067-73.
    View in: PubMed
    Score: 0.083
  46. Postgenomic approaches to cholera vaccine development. Expert Rev Vaccines. 2006 Jun; 5(3):337-46.
    View in: PubMed
    Score: 0.083
  47. Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection. Infect Immun. 2005 Aug; 73(8):4488-93.
    View in: PubMed
    Score: 0.078
  48. The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad. J Pediatric Infect Dis Soc. 2022 Mar 25.
    View in: PubMed
    Score: 0.062
  49. The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients. Microbiol Spectr. 2022 Mar 21; e0021122.
    View in: PubMed
    Score: 0.062
  50. Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. Science. 2022 01 21; 375(6578):eabl6251.
    View in: PubMed
    Score: 0.061
  51. Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2022 01; 16(1):e0010102.
    View in: PubMed
    Score: 0.061
  52. A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients. mSystems. 2021 Aug 31; 6(4):e0088921.
    View in: PubMed
    Score: 0.060
  53. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine. Infect Immun. 2021 08 16; 89(9):e0021721.
    View in: PubMed
    Score: 0.060
  54. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates. Cell Host Microbe. 2021 09 08; 29(9):1437-1453.e8.
    View in: PubMed
    Score: 0.059
  55. Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay. J Clin Pathol. 2021 Aug; 74(8):496-503.
    View in: PubMed
    Score: 0.059
  56. An assessment of potential biomarkers of environment enteropathy and its association with age and microbial infections among children in Bangladesh. PLoS One. 2021; 16(4):e0250446.
    View in: PubMed
    Score: 0.058
  57. Predicting Vibrio cholerae Infection and Disease Severity Using Metagenomics in a Prospective Cohort Study. J Infect Dis. 2021 02 03; 223(2):342-351.
    View in: PubMed
    Score: 0.057
  58. Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates. bioRxiv. 2021 Jan 19.
    View in: PubMed
    Score: 0.057
  59. Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018. Am J Trop Med Hyg. 2021 01 18; 104(3):1079-1084.
    View in: PubMed
    Score: 0.057
  60. Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. Science. 2021 02 05; 371(6529).
    View in: PubMed
    Score: 0.057
  61. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020 10 08; 5(52).
    View in: PubMed
    Score: 0.056
  62. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh. Int J Infect Dis. 2020 Dec; 101:220-225.
    View in: PubMed
    Score: 0.056
  63. Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: A guide and case study in setting up an emergency-use, laboratory-developed molecular assay. medRxiv. 2020 Sep 01.
    View in: PubMed
    Score: 0.056
  64. Prescribing Patterns of Antibiotics for the Self-Treatment of Travelers' Diarrhea in Global TravEpiNet, 2009-2018. Open Forum Infect Dis. 2020 Oct; 7(10):ofaa376.
    View in: PubMed
    Score: 0.056
  65. Phylogenetic analysis of SARS-CoV-2 in the Boston area highlights the role of recurrent importation and superspreading events. medRxiv. 2020 Aug 25.
    View in: PubMed
    Score: 0.056
  66. Dynamics and significance of the antibody response to SARS-CoV-2 infection. medRxiv. 2020 Jul 20.
    View in: PubMed
    Score: 0.055
  67. Characteristics and preparation of the last-minute traveler: analysis of vaccine usage in the Global TravEpiNet Consortium. J Travel Med. 2019 09 02; 26(6).
    View in: PubMed
    Score: 0.052
  68. Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae. mSphere. 2019 08 21; 4(4).
    View in: PubMed
    Score: 0.052
  69. The Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States. Clin Infect Dis. 2019 07 02; 69(2):306-315.
    View in: PubMed
    Score: 0.051
  70. Vibriocidal Titer and Protection From Cholera in Children. Open Forum Infect Dis. 2019 Apr; 6(4):ofz057.
    View in: PubMed
    Score: 0.050
  71. Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter. Open Forum Infect Dis. 2018 Nov; 5(11):ofy266.
    View in: PubMed
    Score: 0.049
  72. Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh. Nat Genet. 2018 07; 50(7):951-955.
    View in: PubMed
    Score: 0.048
  73. Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways. Infect Immun. 2018 02; 86(2).
    View in: PubMed
    Score: 0.047
  74. Enabling clinicians to easily find location-based travel health recommendations-is innovation needed? J Travel Med. 2018 01 01; 25(1).
    View in: PubMed
    Score: 0.046
  75. Vibrio cholerae genomic diversity within and between patients. Microb Genom. 2017 12; 3(12).
    View in: PubMed
    Score: 0.046
  76. Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel. Obstet Gynecol. 2017 12; 130(6):1357-1365.
    View in: PubMed
    Score: 0.046
  77. Pre-Travel Medical Preparation of Business and Occupational Travelers: An Analysis of the Global TravEpiNet Consortium, 2009 to 2012. J Occup Environ Med. 2016 Jan; 58(1):76-82.
    View in: PubMed
    Score: 0.040
  78. Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014. PLoS Negl Trop Dis. 2015 Nov; 9(11):e0004183.
    View in: PubMed
    Score: 0.040
  79. Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015 Nov; 93(5):1110-1116.
    View in: PubMed
    Score: 0.039
  80. Cholera in pregnancy: Clinical and immunological aspects. Int J Infect Dis. 2015 Oct; 39:20-4.
    View in: PubMed
    Score: 0.039
  81. Gut microbial succession follows acute secretory diarrhea in humans. mBio. 2015 May 19; 6(3):e00381-15.
    View in: PubMed
    Score: 0.039
  82. Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection. J Infect Dis. 2015 Sep 01; 212(5):779-83.
    View in: PubMed
    Score: 0.038
  83. Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera. Infect Immun. 2015 Mar; 83(3):1089-103.
    View in: PubMed
    Score: 0.038
  84. Household Transmission of Vibrio cholerae in Bangladesh. PLoS Negl Trop Dis. 2014 Nov; 8(11):e3314.
    View in: PubMed
    Score: 0.037
  85. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2014 Oct; 91(4):738-42.
    View in: PubMed
    Score: 0.037
  86. Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet. Am J Trop Med Hyg. 2014 Oct; 91(4):694-698.
    View in: PubMed
    Score: 0.037
  87. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. PLoS Negl Trop Dis. 2014 May; 8(5):e2828.
    View in: PubMed
    Score: 0.036
  88. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg. 2014 May; 90(5):873-81.
    View in: PubMed
    Score: 0.036
  89. Cellular and cytokine responses to Salmonella enterica serotype Typhi proteins in patients with typhoid fever in Bangladesh. Am J Trop Med Hyg. 2014 Jun; 90(6):1024-1030.
    View in: PubMed
    Score: 0.036
  90. Pre-travel preparation of US travelers going abroad to provide humanitarian service, Global TravEpiNet 2009-2011. Am J Trop Med Hyg. 2014 Mar; 90(3):553-559.
    View in: PubMed
    Score: 0.035
  91. Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium. Vector Borne Zoonotic Dis. 2014 Feb; 14(2):160-7.
    View in: PubMed
    Score: 0.035
  92. Pre-Travel Health Preparation of Pediatric International Travelers: Analysis From the Global TravEpiNet Consortium. J Pediatric Infect Dis Soc. 2013 Dec; 2(4):327-34.
    View in: PubMed
    Score: 0.035
  93. Economics of malaria prevention in US travelers to West Africa. Clin Infect Dis. 2014 Jan; 58(1):11-21.
    View in: PubMed
    Score: 0.034
  94. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vaccine Immunol. 2013 Oct; 20(10):1592-8.
    View in: PubMed
    Score: 0.034
  95. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011. Am J Trop Med Hyg. 2013 May; 88(5):954-961.
    View in: PubMed
    Score: 0.033
  96. High depth, whole-genome sequencing of cholera isolates from Haiti and the Dominican Republic. BMC Genomics. 2012 Sep 11; 13:468.
    View in: PubMed
    Score: 0.032
  97. Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh. Am J Trop Med Hyg. 2012 Nov; 87(5):921-6.
    View in: PubMed
    Score: 0.032
  98. Cholera. Lancet. 2012 Jun 30; 379(9835):2466-2476.
    View in: PubMed
    Score: 0.032
  99. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol. 2012 Aug; 19(8):1304-11.
    View in: PubMed
    Score: 0.032
  100. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin Vaccine Immunol. 2012 Jun; 19(6):842-8.
    View in: PubMed
    Score: 0.031
  101. Individuals with Le(a+b-) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1413.
    View in: PubMed
    Score: 0.031
  102. LPLUNC1 modulates innate immune responses to Vibrio cholerae. J Infect Dis. 2011 Nov; 204(9):1349-57.
    View in: PubMed
    Score: 0.030
  103. Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans. Clin Vaccine Immunol. 2011 Aug; 18(8):1371-7.
    View in: PubMed
    Score: 0.029
  104. Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis. 2011; 5(5):e1145.
    View in: PubMed
    Score: 0.029
  105. Mucosal immunologic responses in cholera patients in Bangladesh. Clin Vaccine Immunol. 2011 Mar; 18(3):506-12.
    View in: PubMed
    Score: 0.029
  106. Relatedness of Vibrio cholerae O1/O139 isolates from patients and their household contacts, determined by multilocus variable-number tandem-repeat analysis. J Bacteriol. 2010 Sep; 192(17):4367-76.
    View in: PubMed
    Score: 0.028
  107. Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh. Infect Immun. 2010 May; 78(5):2117-24.
    View in: PubMed
    Score: 0.027
  108. Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1. Scand J Infect Dis. 2010; 42(1):48-56.
    View in: PubMed
    Score: 0.027
  109. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009 Nov 15; 49(10):1473-9.
    View in: PubMed
    Score: 0.026
  110. Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh. Infect Immun. 2010 Jan; 78(1):253-9.
    View in: PubMed
    Score: 0.026
  111. Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever. Clin Vaccine Immunol. 2009 Nov; 16(11):1587-94.
    View in: PubMed
    Score: 0.026
  112. Memory T-cell responses to Vibrio cholerae O1 infection. Infect Immun. 2009 Nov; 77(11):5090-6.
    View in: PubMed
    Score: 0.026
  113. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun. 2009 Sep; 77(9):3850-6.
    View in: PubMed
    Score: 0.026
  114. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl Trop Dis. 2009; 3(3):e403.
    View in: PubMed
    Score: 0.025
  115. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr Infect Dis J. 2008 Nov; 27(11):986-92.
    View in: PubMed
    Score: 0.025
  116. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J Infect Dis. 2008 Oct 01; 198(7):1055-61.
    View in: PubMed
    Score: 0.024
  117. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis. 2008 Apr 09; 2(4):e221.
    View in: PubMed
    Score: 0.024
  118. Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea. Proc Natl Acad Sci U S A. 2007 Nov 27; 104(48):19091-6.
    View in: PubMed
    Score: 0.023
  119. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005 Nov; 73(11):7422-7.
    View in: PubMed
    Score: 0.020
  120. Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse. Infect Immun. 2005 Oct; 73(10):6674-9.
    View in: PubMed
    Score: 0.020
  121. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J Infect Dis. 2004 Jun 15; 189(12):2318-22.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.